Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity.

Harrington RA, Barac A, Brush JE Jr, Hill JA, Krumholz HM, Lauer MS, Sivaram CA, Taubman MB, Williams JL.

J Am Coll Cardiol. 2015 May 5;65(17):1899-906. doi: 10.1016/j.jacc.2015.03.032. Epub 2015 Mar 13. Review. No abstract available.

2.

EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.

Fu J, Taubman MB.

Mol Cell Biol. 2013 Aug;33(15):3050-61. doi: 10.1128/MCB.00273-13. Epub 2013 Jun 3.

3.

ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.

Rong JX, Blachford C, Feig JE, Bander I, Mayne J, Kusunoki J, Miller C, Davis M, Wilson M, Dehn S, Thorp E, Tabas I, Taubman MB, Rudel LL, Fisher EA.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):4-12. doi: 10.1161/ATVBAHA.112.252056. Epub 2012 Nov 8.

4.

Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells.

Dhawan L, Liu B, Pytlak A, Kulshrestha S, Blaxall BC, Taubman MB.

Mol Cell Biol. 2012 Sep;32(18):3768-75. doi: 10.1128/MCB.00846-12. Epub 2012 Jul 16.

5.

Vascular effects of ultrafine particles in persons with type 2 diabetes.

Stewart JC, Chalupa DC, Devlin RB, Frasier LM, Huang LS, Little EL, Lee SM, Phipps RP, Pietropaoli AP, Taubman MB, Utell MJ, Frampton MW.

Environ Health Perspect. 2010 Dec;118(12):1692-8. doi: 10.1289/ehp.1002237. Epub 2010 Sep 7.

6.

Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells.

Liu B, Dhawan L, Blaxall BC, Taubman MB.

Mol Cell Biochem. 2010 Nov;344(1-2):73-9. doi: 10.1007/s11010-010-0530-6. Epub 2010 Jul 4.

PMID:
20607592
7.

Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

Fu J, Taubman MB.

J Biol Chem. 2010 Mar 19;285(12):8927-35. doi: 10.1074/jbc.M109.078600. Epub 2010 Jan 10.

8.

Platelets and megakaryocytes contain functional nuclear factor-kappaB.

Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):591-8. doi: 10.1161/ATVBAHA.109.197343. Epub 2009 Dec 30.

9.

Role of tissue factor in cancer.

Kasthuri RS, Taubman MB, Mackman N.

J Clin Oncol. 2009 Oct 10;27(29):4834-8. doi: 10.1200/JCO.2009.22.6324. Epub 2009 Sep 8. Review.

10.

Foxp3 regulates megakaryopoiesis and platelet function.

Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP.

Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1874-82. doi: 10.1161/ATVBAHA.109.193805. Epub 2009 Aug 6.

11.

Platelet proteome changes associated with diabetes and during platelet storage for transfusion.

Springer DL, Miller JH, Spinelli SL, Pasa-Tolic L, Purvine SO, Daly DS, Zangar RC, Jin S, Blumberg N, Francis CW, Taubman MB, Casey AE, Wittlin SD, Phipps RP.

J Proteome Res. 2009 May;8(5):2261-72. doi: 10.1021/pr800885j.

12.

Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.

Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA.

Cancer Invest. 2009 May;27(4):430-4. doi: 10.1080/07357900802527247.

PMID:
19219655
13.

The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.

Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP.

Immunol Res. 2009 Dec;45(2-3):251-60. doi: 10.1007/s12026-009-8106-9. Epub 2009 Jan 29. Review.

14.

Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.

Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB.

Blood. 2009 Jan 15;113(3):705-13. doi: 10.1182/blood-2007-05-090944. Epub 2008 Oct 17.

15.

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.

Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB.

J Thromb Haemost. 2008 Nov;6(11):1983-5. doi: 10.1111/j.1538-7836.2008.03156.x. Epub 2008 Sep 15. No abstract available.

16.

15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.

O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, Palis J, Seweryniak KE, Gertz JM, Phipps RP.

Blood. 2008 Nov 15;112(10):4051-60. doi: 10.1182/blood-2008-05-158535. Epub 2008 Aug 28.

17.

The role of smooth muscle derived tissue factor in mediating thrombosis and arterial injury.

Taubman MB, Wang L, Miller C.

Thromb Res. 2008;122 Suppl 1:S78-81. doi: 10.1016/S0049-3848(08)70025-2. Review.

PMID:
18691507
18.

Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.

Alexis JD, Pyo RT, Chereshnev I, Katz J, Rollins BJ, Charo IF, Taubman MB.

J Vasc Res. 2008;45(6):538-46. doi: 10.1159/000129688. Epub 2008 May 7.

PMID:
18463419
19.

Does tissue factor expression by vascular smooth muscle cells provide a link between C-reactive protein and cardiovascular disease?

Mackman N, Taubman MB.

Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):601-3. doi: 10.1161/ATVBAHA.108.165050. Review. No abstract available.

PMID:
18354090
20.

The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Spinelli SL, O'Brien JJ, Bancos S, Lehmann GM, Springer DL, Blumberg N, Francis CW, Taubman MB, Phipps RP.

PPAR Res. 2008;2008:328172. doi: 10.1155/2008/328172.

21.

Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.

Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP.

Thromb Haemost. 2008 Jan;99(1):86-95. doi: 10.1160/TH07-05-0328.

22.

Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L583-90. Epub 2007 Jun 22.

23.

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.

Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB.

Clin Cancer Res. 2007 May 15;13(10):2870-5.

24.

Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease.

Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB.

J Thromb Haemost. 2007 May;5(5):942-9.

25.

EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability.

Fu J, Menzies K, Freeman RS, Taubman MB.

J Biol Chem. 2007 Apr 27;282(17):12410-8. Epub 2007 Mar 6.

26.

A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability.

Dhawan L, Liu B, Blaxall BC, Taubman MB.

J Biol Chem. 2007 Apr 6;282(14):10146-52. Epub 2007 Feb 2.

27.

The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands.

O'Brien JJ, Ray DM, Spinelli SL, Blumberg N, Taubman MB, Francis CW, Wittlin SD, Phipps RP.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76. Epub 2006 Jul 10. Review.

PMID:
17164134
28.

PDGF-BB enhances monocyte chemoattractant protein-1 mRNA stability in smooth muscle cells by downregulating ribonuclease activity.

Liu B, Poon M, Taubman MB.

J Mol Cell Cardiol. 2006 Jul;41(1):160-9. Epub 2006 May 23.

PMID:
16720030
29.

Identification and characterization of murine alternatively spliced tissue factor.

Bogdanov VY, Kirk RI, Miller C, Hathcock JJ, Vele S, Gazdoiu M, Nemerson Y, Taubman MB.

J Thromb Haemost. 2006 Jan;4(1):158-67.

30.

Tissue factor is induced in a rodent model of severe pulmonary hypertension characterized by neointimal lesions typical of human disease.

White RJ, Galaria II, Harvey J, Blaxall BC, Cool CD, Taubman MB.

Chest. 2005 Dec;128(6 Suppl):612S-613S. No abstract available.

PMID:
16373864
31.

EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.

Campagnolo L, Leahy A, Chitnis S, Koschnick S, Fitch MJ, Fallon JT, Loskutoff D, Taubman MB, Stuhlmann H.

Am J Pathol. 2005 Jul;167(1):275-84.

32.

Chemokines in the pathogenesis of vascular disease.

Charo IF, Taubman MB.

Circ Res. 2004 Oct 29;95(9):858-66. Review.

PMID:
15514167
33.
34.

Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3.

Pyo R, Jensen KK, Wiekowski MT, Manfra D, Alcami A, Taubman MB, Lira SA.

Am J Pathol. 2004 Jun;164(6):2289-97.

35.

CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.

Kodali RB, Kim WJ, Galaria II, Miller C, Schecter AD, Lira SA, Taubman MB.

Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1211-6. Epub 2004 May 6.

PMID:
15130922
36.

Regulation of the SM-20 prolyl hydroxylase gene in smooth muscle cells.

Menzies K, Liu B, Kim WJ, Moschella MC, Taubman MB.

Biochem Biophys Res Commun. 2004 May 7;317(3):801-10.

PMID:
15081411
37.

MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells.

Schecter AD, Berman AB, Yi L, Ma H, Daly CM, Soejima K, Rollins BJ, Charo IF, Taubman MB.

J Leukoc Biol. 2004 Jun;75(6):1079-85. Epub 2004 Mar 12.

PMID:
15020650
38.

Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.

Haque NS, Fallon JT, Pan JJ, Taubman MB, Harpel PC.

Blood. 2004 Feb 15;103(4):1296-304. Epub 2003 Oct 23.

39.

MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.

Kim WJ, Chereshnev I, Gazdoiu M, Fallon JT, Rollins BJ, Taubman MB.

Biochem Biophys Res Commun. 2003 Oct 24;310(3):936-42.

PMID:
14550294
40.

Chemokine receptors in vascular smooth muscle.

Schecter AD, Berman AB, Taubman MB.

Microcirculation. 2003 Jun;10(3-4):265-72. Review.

PMID:
12851644
41.

Angiotensin II: a vasoactive hormone with ever-increasing biological roles.

Taubman MB.

Circ Res. 2003 Jan 10;92(1):9-11. No abstract available.

PMID:
12522114
42.

Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells.

Rong JX, Berman JW, Taubman MB, Fisher EA.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1617-23.

PMID:
12377739
43.

Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.

Lieb ME, Menzies K, Moschella MC, Ni R, Taubman MB.

Biochem Cell Biol. 2002;80(4):421-6.

PMID:
12234095
44.

CCR2 deficiency decreases intimal hyperplasia after arterial injury.

Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimon JJ, Charo IF, Taubman MB.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):554-9.

PMID:
11950690
45.

HIV envelope gp120 activates human arterial smooth muscle cells.

Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, Taubman MB.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10142-7. Epub 2001 Aug 14.

46.

Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model.

Roqué M, Reis ED, Cordon-Cardo C, Taubman MB, Fallon JT, Fuster V, Badimon JJ.

Lab Invest. 2001 Jun;81(6):895-903.

PMID:
11406650
47.

Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits.

Poon M, Gertz SD, Fallon JT, Wiegman P, Berman JW, Sarembock IJ, Taubman MB.

Atherosclerosis. 2001 Apr;155(2):371-80.

PMID:
11254907
48.

Expression of Q227L-Galpha(s) inhibits intimal vessel wall hyperplasia after balloon injury.

Holness W, Santore TA, Brown GP, Fallon JT, Taubman MB, Iyengar R.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1288-93.

50.

Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty.

Roqué M, Reis ED, Fuster V, Padurean A, Fallon JT, Taubman MB, Chesebro JH, Badimon JJ.

J Am Coll Cardiol. 2000 Dec;36(7):2303-10.

Supplemental Content

Loading ...
Support Center